Matthew Keller Stock Analyst Profile - HC Wainwright & Co. Research Coverage - Stocknear

Matthew Keller

Stock Analyst at HC Wainwright & Co.

(4.14)
# 1915
Out of 5,478 analysts
6
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:
6 Stocks
Name Action PT Current % Upside Ratings Updated
IFRX InflaRx
Assumes: Buy
6
1.47 308.16% 1 Sep 2, 2025
GYRE Gyre Therapeutics
Initiates Coverage On: Buy
18
8.12 121.67% 1 Aug 26, 2025
PHIO Phio Pharma
Reiterates: Buy
14 14
2.32 503.45% 1 Aug 15, 2025
GALT Galectin Therapeutic...
Reiterates: Buy
6 6
5.94 1.01% 1 Aug 14, 2025
ACXP Acurx Pharmaceutical...
Maintains: Strong Buy
8 31
4.28 624.3% 1 Aug 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
10 43
12.43 245.94% 1 Aug 7, 2025